Collaborative agreements pharmaceuticals

The development and commercialization of products with pharmaceutical and agricultural companies in the fields of human health, nutrition, crop production, and industrial products are their final objectives. Collaboration agreements with the partners entitle to committed funding, performance-based fees, and royalty payments for any products that might emerge from the collaborations. 

In addition to obtaining a Medicaid provider number, a pharmacist must produce two other documents prior to providing pharmaceutical care in Mississippi a written evaluation and treatment protocol and a referral from a physician. The protocol must define the collaborative agreement between the pharmacist and the referring physician and be on file with the State Board of Pharmacy. The nature of protocol requirements differs among practice sites. Within an institution, one protocol agreement may be submitted for all the physicians... 

Large-scale collaborations between pharmaceutical companies and academia are largely a phenomenon of biology and pharmacology (5 11). Although these agreements may represent extensive support and collaborative opportunities for the faculty involved, they are relatively infrequent. Table 9-2 lists the bulk of such relationships of direct or indirect relevance to the pharmaceutical industry. In some cases, the industrial partner may create an entire physical structure in which industrially-supported work... 

Program maintains an in-house capability to study the malaria parasite itself, to discover, develop, and evaluate new compounds, and to develop collaborative agreements with other public organizations such as the World Health Organization (WHO) and private pharmaceutical firms for clinical testing and potential marketing successful compounds. 

Most of the collaborations in North America are R D agreements (see Figure 4.4) but there is a significant amount of cross-border collaborative activity involving Asia (Kang and Sakai 2000 OECD 2001). The relative significance of American pharmaceutical... 

The replacement of chlorofluorocarbon (CFC) propellants with the non-ozone-depleting hydrofluorocarbons (HFCs) merit mention for two reasons. First, it illustrates how environmental impact can be an important selection criterion at a time when green issues are high profile. Second, HFCs were developed and evaluated for safety and delivery capability by a consortium of pharmaceutical companies, with costs shared and evaluation programs defined by prior agreement between end-users and propellant manufacturers. Such collaboration could be employed usefully in the future to develop novel excipients for delivery or targeting. The benefits would undoubtedly accrue to all. 

Pharmaceutical care has become the philosophy of pharmacy practice in recent years, as well as a mission or purpose for the profession, ffowever, another term that has come into use to simultaneously describe pharmaceutical care and the system for the medication use proces.s— CDTM. As the healthcare system grows in complexity, pharmaceutical care becomes increasingly important. It becomes more and more necessary for pharmacists, physicians, and other health professionals to work together in collaboration to assure safe use of medication. CDTM is an innovative approach in which pharmaceutical care services can be provided by a pharmacist in a supportive healthcare environment after a process of credential-ing, privileging, and approval of a Collaborative Practice Agreement. 

Ryan, M. In Collaborative Care Agreements to Facilitate Pharmaceutical Care. International Pharmaceutical Abstracts, 32nd American Society of Health-System Pharmacists Midyear Clinical Meeting, Atlanta, Georgia, Dec. 7-11, 1997 American Society of Health-System Pharmacists Washington, DC, 1997, 3412273, 2164. 

---